Skip to main content

Table 1 Demographic and disease characteristics in patients with ulcerative colitis (UC) with fatigue and none fatigue

From: Prevalence and factors associated with fatigue in patients with ulcerative colitis in China: a cross-sectional study

Variables

Total (n = 220)

Fatigue (n = 136)

None fatigue(n = 84)

P value

Gender, n (%)

Male

131 (59.5)

80 (58.8)

51 (60.7)

0.781

Female

89 (40.5)

56 (41.2)

33 (39.3)

 

Age, year, median (IQR)

45 (33–56)

44 (32–56)

48 (35–57)

0.177

Education, n (%)

Master degree or above

9 (4.1)

5(3.7)

4(4.8)

0.861

Undergraduate

62 (28.2)

37 (27.2)

25 (29.8)

 

Junior college

39 (17.7)

23 (16.9)

16 (19.0)

 

Senior high school or below

110 (50.0)

71 (52.2)

39 (46.4)

 

Employment status, n (%)

Full time or part time

151 (68.6)

91 (66.9)

60 (71.4)

0.134

No work

15 (6.8)

13 (9.6)

2 (2.4)

 

Retired

37 (16.8)

20 (14.7)

17 (20.2)

 

Other

17 (7.7)

12 (8.8)

5 (6.0)

 

Only child, n (%)

Yes

70 (31.8)

47(34.6)

23(27.4)

0.267

No

150 (68.2)

89(65.4)

61 (72.6)

 

Disease duration, year, median (IQR)

3.9 (1.3–7.9)

4.0 (1.4–8.0)

3.8 (1.1–6.7)

0.649

Montreal classification, n (%)

E1

39 (17.7)

16 (11.8)

23 (27.4)

 < 0.001

E2

66 (30.0)

33 (24.3)

33 (39.3)

 

E3

115 (52.3)

87 (64.0)

28 (33.3)

 

Disease activity, n (%)

Remission

50 (22.7)

20 (14.7)

30 (35.7)

 < 0.001

Mild

88 (40.0)

47 (34.6)

41 (48.8)

 

Moderate

59 (26.8)

47 (34.6)

12 (14.3)

 

Severe

23 (10.5)

22 (16.2)

1 (1.19)

 

EIM, n (%)

Yes

65 (29.5)

38 (27.9)

27 (32.1)

0.507

No

155 (70.5)

98 (72.1)

57 (67.9)

 

Complications, n (%)

Yes

12 (5.5)

5 (3.68)

7 (8.3)

0.241

No

208 (94.5)

131 (96.3)

77 (91.7)

 

Medication have been used, n (%)

5-ASA

216 (98.2)

133 (97.8)

83 (98.8)

0.686

Immunosuppressants

10 (4.5)

6 (4.4)

4 (4.8)

 

Corticosteroids

57 (25.9)

40 (29.4)

17 (20.2)

 

Biologic treatment

8 (3.6)

5 (3.7)

3 (3.6)

 

IBD related surgery, n (%)

Yes

10 (4.5)

8 (5.9)

2 (2.4)

0.226

No

210 (95.5)

128 (94.1)

82 (97.6)

 

Anemia

Yes

49 (22.3)

38 (77.6)

11 (22.5)

0.01

No

171(77.7)

98 (57.3)

73 (42.7)

 

Smoking status, n (%)

Yes

42(19.1)

26 (19.1)

16 (19.0)

0.99

No

178(80.9)

110 (80.9)

68 (81.0)

 

Drinking status, n (%)

Yes

185 (80.1)

21 (15.4)

14 (16.7)

0.809

No

35 (15.9)

115 (84.6)

70 (83.3)

 

BMI, n (%)

Thinnish

34 (15.5)

24 (17.6)

10 (11.9)

0.32

Normal

136 (61.8)

79 (58.1)

57 (67.9)

 

Overweight or Obesity

50 (22.7)

33 (24.3)

17 (20.2)

 

FSS, median (IQR)

4.4 (3.3–5.9)

5.4 (4.6–6.3)

2.7 (2.0–3.3)

 < 0.001

MFI, median (IQR)

61 (48–73)

68.5 (60–78)

48 (37.3–58)

 < 0.001

HAS, median (IQR)

5 (3–8)

7 (4–10)

4 (2–6)

 < 0.001

HDS, median (IQR)

6 (3–9)

7 (4–10)

5 (2.25–7)

 < 0.001

PSQI, median (IQR)

6 (4–9)

7 (5–10)

5 (3–8)

0.001

MUST, median (IQR)

1 (0–2)

1 (0–2)

0 (0–1)

0.001

  1. IQR indicates interquartile range, E1, Proctitis; E2, Left side colitis; E3, Extensive colitis; EIM extra-intestinal manifestations; 5-ASA 5-aminosalisylic acid, IBD inflammatory bowel disease, BMI body mass index, HAS hospital anxiety scale, HDS hospital depression scale, PSQI pittsburgh sleep quality index, MUST malnutrition universal screening tool